Iterum Secures $65 Million in Series B Financing

Funding to support the Phase 3 clinical development of oral penem antibiotic DUBLIN and CHICAGO, May 19, 2017 -- (Healthcare Sales & Marketing Network) -- Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the develo... Biopharmaceuticals, Venture Capital, Personnel Iterum Therapeutics, sulopenem
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news